SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Dishman Pharmaceuticals & Chemicals

Dishman Pharmaceuticals & Chemicals

BSE: 532526|NSE: DISHMAN|ISIN: INE353G01020|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Jul 22, 16:01
146.40
4.3 (3.03%)
VOLUME 324,052
LIVE
NSE
Jul 22, 16:01
146.55
4.5 (3.17%)
VOLUME 2,025,070
News on Dishman Pharmaceuticals & Chemicals
Select Year: 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
ITC, Cairn India, Biocon, Zensar, Syngene in focus post Q1 nos 

8.52 am | 22 Jul 2016 |  Source: CNBC-TV18

Some of the stocks that should be on your radar are: Sun TV Network, Dishman Pharmaceuticals & Chemicals, ITC, Cairn India, Axis Bank, Biocon, Syngene...

Prefer Sun Pharma, Dr Reddy's Lab: Sharmila Joshi 

4.38 pm | 19 Jul 2016 |  Source: CNBC-TV18

Sharmila Joshi of sharmilajoshi.com is of the view that one may prefer Sun Pharmaceutical Industries and Dr Reddy's Laboratories....

Dishman Pharma's Swiss units clear US FDA inspection 

2.58 pm | 14 Jul 2016 |  Source: CNBC-TV18

Dishman Pharma’s all global plants, except China, have been cleared by the US FDA, says JR Vyas, CMD of the company. ...

Dishman Pharma up 7%, receives EIR for 2 units in Switzerland

1.28 pm | 14 Jul 2016 |  Source: Moneycontrol.com

The company's subsidiary Carbogen Amcis AG, Switzerland, had successfully completed USFDA inspection for its two sites located at Aarau and Neuland wi...

Dishman Pharma receives establishment inspection report for 2 units in Switzerland

1.05 pm | 14 Jul 2016 |  Source: Moneycontrol.com

Dishman Pharmaceuticals' subsidiary Carbogen Amcis AG, Switzerland, had successfully completed USFDA inspection for its two sites located at Aarau and...

Top buzzing midcap stocks to trade on July 11 

12.23 pm | 11 Jul 2016 |  Source: CNBC-TV18

Here are a few top buzzing midcap stocks picked by CNBC-TV18's analysts in trade today. We have Bharat Financial Inclusion, Coal India, Dishman Pharma...

Exports to US will continue normally post audit: Dishman Pharma 

11.53 am | 11 Jul 2016 |  Source: CNBC-TV18

Two minor observations pertaining to a 2014 audit were reported by the US FDA in its recent inspection, says JR Vyas, CMD of Dishman Pharma....

Stocks that must be on your radar 

9.05 am | 11 Jul 2016 |  Source: CNBC-TV18

Some of the stocks that should be on your radar are: Torrent Pharmaceuticals, Glenmark Pharma, Alkem Laboratories, AstraZeneca Pharma, Aurobindo Pharm...

Stocks in news: L&T, Bharti, Tata Steel, Claris, Dishman, Zydus

8.01 am | 11 Jul 2016 |  Source: CNBC-TV18

Larsen and Toubro | Bharti Airtel | Tata Motors | Tata Steel | Vedanta | Aurobindo Pharma | Claris Lifesciences | Cadila Health | Dishman Pharma | Fin...

Buy Dishman Pharma; target of Rs 200: Dynamic Levels

3.53 pm | 01 Jul 2016 |  Source: Moneycontrol.com

Dynamic Levels is bullish on Dishman Pharma has recommended buy rating on the stock with a target price of Rs 200 in its research report dated June 30...

Buy Dishman Pharma, says Ashu Madan 

3.27 pm | 16 Jun 2016 |  Source: CNBC-TV18

Ashu Madan of Religare Securities advises buying Dishman Pharma....

Dishman Q4 net profit up 29% at Rs 50 cr

4.00 pm | 19 May 2016 |  Source: PTI

The company, which today announced plans to sell 50 percent stake in joint venture Schutz Dishman for three lakh euros to its promoters, had reported ...

Dishman Pharmaceuticals Q3 net up two-fold to Rs 47 cr

6.22 pm | 05 Feb 2016 |  Source: PTI

Drug firm Dishman Pharmaceuticals and Chemicals today reported a nearly two-fold jump in consolidated net profit to Rs 46.93 crore for the quarter ...

1 2
Quick Links for Dishman Pharmaceuticals & Chemicals
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.